Search Results - "Nicol, Steven"

Chemotherapy treatment patterns, costs, and outcomes of patients with gastric cancer in the United States: a retrospective analysis of electronic medical record (EMR) and administrative claims data by Hess, Lisa M., Michael, Diane, Mytelka, Daniel S., Beyrer, Julie, Liepa, Astra M., Nicol, Steven

“…Background The aim of this study was to conduct a retrospective database analysis to describe the chemotherapy treatment patterns and outcomes of patients with…”
Get full text

Phase II Study of Pemetrexed for Second-Line Treatment of Transitional Cell Cancer of the Urothelium by Sweeney, Christopher J, Roth, Bruce J, Kabbinavar, Fairooz F, Vaughn, David J, Arning, Michael, Curiel, Rafael E, Obasaju, Coleman K, Wang, Yanping, Nicol, Steven J, Kaufman, Donald S

“…To assess the antitumor activity and toxicity of pemetrexed as second-line chemotherapy in patients with locally advanced or metastatic transitional cell…”
Get full text

The Patient Experience with Soft Tissue Sarcoma: A Systematic Review of the Literature by Winnette, Randall, Hess, Lisa M., Nicol, Steven J., Tai, Datchen Fritz, Copley-Merriman, Catherine

“…Background Soft tissue sarcomas (STS) are a heterogenous group of rare tumors that involve the connective tissue in the body (e.g. muscle, tendons). As with…”
Get full text

Full-Dose Gemcitabine With Concurrent Radiation Therapy in Patients With Nonmetastatic Pancreatic Cancer: A Multicenter Phase II Trial by SMALL, William, BERLIN, Jordan, KINSELLA, Timothy J, MERCHANT, Nipun B, HOFFMAN, John P, BENSON, Al B, NICOL, Steven, XU, Rong M, GILL, John F, MCGINN, Cornelius J, FREEDMAN, Gary M, LAWRENCE, Theodore, TALAMONTI, Mark S, MULCAHY, Mary F, BAPSI CHAKRAVARTHY, A, KONSKI, Andre A, ZALUPSKI, Mark M, PHILIP, Philip A

“…Gemcitabine is effective in the treatment of pancreatic cancer and is a potent radiosensitizer. This study assessed safety and efficacy of full-dose…”
Get full text

KRAS testing of patients with metastatic colorectal cancer in a community-based oncology setting: a retrospective database analysis by Carter, Gebra Cuyun, Landsman-Blumberg, Pamela B, Johnson, Barbara H, Juneau, Paul, Nicol, Steven J, Li, Li, Shankaran, Veena

“…In 2009, treatment guidelines were updated to recommend KRAS testing at diagnosis for patients with metastatic colorectal cancer (mCRC). We investigated KRAS…”
Get full text

Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma by Butowski, Nicholas, Chang, Susan M., Lamborn, Kathleen R., Polley, Mei-Yin, Pieper, Russell, Costello, Joseph F., Vandenberg, Scott, Parvataneni, Rupa, Nicole, Angelina, Sneed, Patricia K., Clarke, Jennifer, Hsieh, Emily, Costa, Bruno M., Reis, Rui M., Hristova-Kazmierski, Maria, Nicol, Steven J., Thornton, Donald E., Prados, Michael D.

“…This open-label, single-arm, phase II study combined enzastaurin with temozolomide plus radiation therapy (RT) to treat glioblastoma multiforme (GBM) and…”
Get full text

Phase II Trial of Gemcitabine Plus Cisplatin in Patients With Metastatic Urothelial Cancer by KAUFMAN, D, RAGHAVAN, D, CARDUCCI, M, LEVINE, E. G, MURPHY, B, AISNER, J, KUZEL, T, NICOL, S, OH, W, STADLER, W

“…To assess the activity and toxicity of the combination of gemcitabine and cisplatin in the treatment of chemotherapy-naive patients with metastatic urothelial…”
Get full text

Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: Results of a Phase II, randomized, noncomparative study by Richards, Donald A., Kuefler, Paul R., Becerra, Carlos, Wilfong, Lalan S., Gersh, Robert H., Boehm, Kristi A., Zhan, Feng, Asmar, Lina, Myrand, Scott P., Hozak, Rebecca R., Zhao, Luping, Gill, John F., Mullaney, Brian P., Obasaju, Coleman K., Nicol, Steven J.

“…Summary Purpose Gemcitabine (G) is standard therapy for pancreatic cancer. Enzastaurin (E) inhibits PKCβ and PI3K/AKT signaling pathways with a dose-dependent…”
Get full text

Multicenter, randomized phase II trial of bevacizumab plus folinic acid, fluorouracil, gemcitabine (FFG) versus bevacizumab plus folinic acid, fluorouracil, oxaliplatin (FOLFOX4) as first-line therapy for patients with advanced colorectal cancer by Madajewicz, Stefan, Waterhouse, David M., Ritch, Paul S., Khan, M. Qaseem, Higby, Donald J., Leichman, Cynthia G., Malik, Sandeep K., Hentschel, Patricia, Gill, John F., Zhao, Luping, Nicol, Steven J.

“…Summary Purpose To assess safety and efficacy of folinic acid, 5-fluorouracil, gemcitabine (FFG) and folinic acid, fluorouracil, oxaliplatin (FOLFOX4) regimens…”
Get full text

Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: a phase I study by Butowski, Nicholas, Chang, Susan M, Lamborn, Kathleen R, Polley, Mei Yin, Parvataneni, R, Hristova-Kazmierski, Maria, Musib, Luna, Nicol, Steven J, Thornton, Donald E, Prados, Michael D

“…We conducted a phase I study to determine the safety and recommended phase II dose of enzastaurin (oral inhibitor of the protein kinase C-beta [PKCbeta] and…”
Get full text

Phase I dose-escalating study of biweekly fixed-dose rate gemcitabine plus pemetrexed in patients with advanced solid tumors by Yuan, Yuan, Cohen, Deirdre J., Love, Erica, Yaw, Michelle, Levinson, Benjamin, Nicol, Steven J., Hochster, Howard S.

“…Purpose To determine the maximum tolerated dose (MTD) and the recommended phase II dose and to identify the dose-limiting toxicities (DLTs) of gemcitabine,…”
Get full text

Metastatic Colorectal Cancer Treatment Patterns According to Kirsten Rat Sarcoma Viral Oncogene Homolog Genotype in U.S. Community-Based Oncology Practices by Landsman-Blumberg, Pamela B, Carter, Gebra Cuyun, Johnson, Barbara H, Sedgley, Robert, Nicol, Steven J, Li, Li, Shankaran, Veena

“…Abstract Introduction In 2008, the National Comprehensive Cancer Network guidelines were revised in light of the identification of the Kirsten Rat Sarcoma…”
Get full text

A phase I study of pemetrexed in patients with relapsed or refractory acute leukemia by Abdel-Karim, Isam, Plunkett, William K., O’Brien, Susan, Giles, Francis, Thomas, Deborah, Faderl, Stefan, Ravandi, Farhad, Rios, Mary Beth, Du, Min, Schneck, Karen B., Chen, Victor J., Lin, Boris K., Nicol, Steven J., Kantarjian, Hagop M.

“…Summary Purpose To investigate the toxicity profile, activity, pharmacokinetics, and pharmacodynamics of pemetrexed in leukemia. Patients and Methods Patients…”
Get full text

A multi-institutional phase II trial of gemcitabine plus paclitaxel in patients with locally advanced or metastatic urothelial cancer by Kaufman, Donald S., Carducci, Michael A., Kuzel, Tim M., Todd, Mary B., Oh, William K., Smith, Matthew R., Ye, Zhishen, Nicol, Steven J., Stadler, Walter M.

“…The purpose of the study was to evaluate response and survival in patients with metastatic urothelial cancer treated with combination gemcitabine and…”
Get full text

Pemetrexed and Oxaliplatin for Metastatic Colorectal Cancer: Results of a Phase I Mayo Cancer Center Research Consortium Trial, MC0248 by Alberts, Steven R, Kim, George P, Mahoney, Michelle R, Gornet, Michael K, Rubin, Joseph, Ames, Matthew, Goetz, Matthew P, Weinshilboum, Richard M, Nicol, Steven J, Goldberg, Richard M

“…Abstract Purpose Pemetrexed, an antifolate involved in purine and pyrimidine formation, is a potential alternative to fluoropyrimidines in the treatment of…”
Get full text

Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: Results of a Phase II, randomized, noncomparative study by Richards, Donald A., Kuefler, Paul R., Becerra, Carlos, Wilfong, Lalan S., Gersh, Robert H., Boehm, Kristi A., Zhan, Feng, Asmar, Lina, Myrand, Scott P., Hozak, Rebecca R., Zhao, Luping, Gill, John F., Mullaney, Brian P., Obasaju, Coleman K., Nicol, Steven J.

Get full text

Costs and Patterns of Gastric Cancer Care in the Us: A Retrospective Analysis of Administrative Claims Data by Lisa, Hess, Daniel, Mytelka, Julie, Beyrer, Steven, Nicol

Get full text

Treatment Patterns and Outcomes of Patients with Gastric Cancer in the Us: A Retrospective Analysis of Electronic Medical Record (EMR) Data by Lisa, Hess, Diane, Michael, Daniel, Mytelka, Julie, Beyrer, Steven, Nicol

Get full text

Understanding the patient experience with soft tissue sarcoma: A systematic review of the literature by Hess, Lisa M., Winnette, Randall, Nicol, Steven, Tai, Datchen Fritz, Copley-Merriman, Kati

“…Abstract only 61 Background: Soft tissue sarcomas (STS) are a heterogenous group of rare tumors that involve the connective tissue in the body. As with many…”
Get full text

Oncologist preferences in advanced soft tissue sarcoma: A discrete choice experiment by Hess, Lisa M., Ivanova, Jasmina I, Horton, Viviana Garcia, Graham, Sophia, Liu, Olivia, Zhu, Yajun, Lorenzo, Maria, Nicol, Steven J.

“…Abstract only 147 Background: Soft-tissue sarcomas (STS), a rare heterogeneous group of cancers originating in the muscle, fat, blood vessels or other…”
Get full text